Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD
Clinical trial NCT06672536 · RECRUITING
Trial details
- NCT number
- NCT06672536
- Sponsor
- Sinocelltech Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-26
- Primary completion
- 2026-09-23
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.